Savaş, E. M. Et Al. 2023. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4 , 236-241.

Savaş, E. M., Yılmaz, S., Başer Dikyar, A. A., Özkurt, Z. N., Öcal, R., Can, F., ... Pepeler, S.(2023). Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, 236-241.

Savaş, Emine Et Al. "Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.," Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, 236-241, 2023

Savaş, Emine M. Et Al. "Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, pp.236-241, 2023

Savaş, E. M. Et Al. (2023) . "Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, pp.236-241.

@article{article, author={Emine Merve Savaş Et Al. }, title={Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.}, journal={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year=2023, pages={236-241} }